Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients

Author: Mizushige Tomoko   Kobori Hiroyuki   Hitomi Hirofumi   Nishijima Yoko   Tomoda Fumihiro   Morimoto Satoshi   Kohno Masakazu   Nishiyama Akira  

Publisher: MDPI

E-ISSN: 1422-0067|17|11|1800-1800

ISSN: 1422-0067

Source: International Journal of Molecular Sciences, Vol.17, Iss.11, 2016-10, pp. : 1800-1800

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content